Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 15:13:307.
doi: 10.25259/SNI_455_2022. eCollection 2022.

Japanese herbal Kampo medicine, Keishibukuryogan, for chronic subdural hematoma - Prospective observational study

Masahito Katsuki  1 , Shin Kawamura  1 , Akihito Koh  1
Affiliations

Japanese herbal Kampo medicine, Keishibukuryogan, for chronic subdural hematoma - Prospective observational study

Masahito Katsuki et al. Surg Neurol Int. .

Abstract

Background: Pharmacological treatment for chronic subdural hematoma (CSDH) recurrence prevention after surgery is under debate. CSDH may be related to suidoku (fluid disturbance) from the Japanese herbal kampo perspective. Goreisan (GRS) treats suidoku and is used to prevent a postoperative recurrence. However, not all CSDHs are liquid, and some have structures such as trabecula, hematoma, and clots, suggesting oketsu (blood stasis). Therefore, we prospectively investigated the keishibukuryogan (KBG) effectiveness, which treats oketsu, for CSDH recurrence prevention and hematoma resolution compared to GRS.

Methods: We prospectively prescribed KBG 7.5 g/day for 12 CSDH patients after burr-hole surgery. As a control cohort, we retrospectively collected 48 patients treated by GRS 7.5 g/day. The recurrence within 1 month and the hematoma thickness after 1 month were evaluated.

Results: The median age was 84 years old. All the patients' symptoms improved after surgery. The median preoperative midline shift and mean hematoma thicknesses were 6.0 mm and 23.75 mm. Those at 1 month were 2.0 mm and 11.43 mm. The recurrence rate was not significantly different between the KBG cohort (1 of 12) and the GRS cohort (4 of 48) (P = 0.999). The KBG's noninferiority to GRS regarding the hematoma thickness at 1 month was statistically proven; KBG (12.26 mm) and GRS (11.20 mm).

Conclusion: The recurrence rate at 1 month was not different between the KBG and GRS cohorts. The hematoma thickness at 1 month in the KBG cohort was not statistically inferior to that in the GRS cohort.

Keywords: Chronic subdural hematoma; Goreisan; Japanese herbal kampo medicine; Keishibukuryogan; Recurrence.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1:
Figure 1:
Hematoma thickness at 1 month. The noninferiority of keishibukuryogan (KBG) to goreisan (GRS) was statistically proved.
See this image and copyright information in PMC

References

    1. Di Cristofori A, Remida P, Patassini M, Piergallini L, Buonanno R, Bruno R, et al. Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives. Surg Neurol Int. 2022;13:94. - PMC - PubMed
    1. Fujii S, Kiyokawa J, Tamada N, Yoshimura M, Hirota S, Yamamoto S, et al. Administration of keishibukuryogan in combination with sennoside may accelerate absorption of intracerebral hematomas: Evaluation of six cases (Japanese) J Neurosurg Kampo Med. 2017;3:41–7.
    1. Fujisawa N, Oya S, Yoshida S, Tsuchiya T, Nakamura T, Indo M, et al. A prospective randomized study on the preventive effect of Japanese Herbal Kampo medicine goreisan for recurrence of chronic subdural hematoma. Neurol Med Chir (Tokyo) 2021;61:12–20. - PMC - PubMed
    1. Karibe H, Kameyama M, Kawase M, Hirano T, Kawaguchi T, Tominaga T. Epidemiology of chronic subdural hematomas. No Shinkei Geka. 2011;39:1149–53. - PubMed
    1. Katayama K, Matsuda N, Kakuta K, Naraoka M, Takemura A, Hasegawa S, et al. The effect of Goreisan on the prevention of chronic subdural hematoma recurrence: Multi-center randomized controlled study. J Neurotrauma. 2018;35:1537–42. - PubMed

LinkOut - more resources